Organic Active Ingredients TRIZ Cases

Guanidine derivatives condense with pyrazole carboxylic acids to synthesize imidazolidine-diones, eliminating hydrazine use and uncontrolled nitrogen release.

Chemotherapeutic agents increase CLDN18.2 levels on pancreatic cancer cells, enabling superior antibody-mediated killing and overcoming treatment resistance.

An annular girdle and dome geometry on a compacted powder tablet prevents jamming in dispensing devices while maintaining structural integrity.

Segmented microcapsules control drug diffusion to maintain seven-day efficacy while reducing skin irritation and waste.

Acidifying agents in oral irinotecan formulations lower pH to prevent rapid deactivation, improving bioavailability and reducing side effects.

Dissolving bendamustine free base in an oily vehicle prevents hydrolysis while surfactants accelerate dissolution for stable oral administration.

Substituted pyrrolopyrimidine compounds inhibit CDK4/CDK6 kinase activity, resolving the trade-off between broad inhibition and off-target effects.

Magnesium-dysprosium alloy slows corrosion kinetics to prevent fragment detachment and restenosis risk.

Administering methylnaltrexone blocks peripheral mu opioid receptors to inhibit tumor growth while preserving central pain relief efficacy.

Synergistic human milk oligosaccharides stimulate innate immunity and colonization resistance, reducing pathogen virulence without antibiotic side effects.

Anti-VEGF-B antibodies inhibit vascular endothelial growth factor-B signaling to preserve kidney structure and function in diabetic nephropathy treatment.

Late-step acyl installation on piperidine scaffolds bypasses acyl migration, boosting sufentanil yield to 43%.

Measuring CLC, GBP3, and B3GNT5 mRNA in maternal blood improves prediction accuracy over conventional markers like fetal fibronectin.

Hydroxybutyrate conjugate acids integrated into soft tissue repair implants provide direct antimicrobial defense mechanisms.

Combining IRAK1 and BCL2 inhibitors eliminates MDS clones via synergistic cytotoxicity, reducing treatment-related toxicities.

Cineraria maritima eye drops combine herbal extracts with NSAIDs to treat cataract symptoms without surgical risks.

Segmenting capping functions into modular trinucleotide units reduces reaction time and purification difficulty while improving translation efficiency.

Coformycin analogs block MTADA to attenuate virulence without suppressing growth, preventing biofilm formation and reducing drug resistance risks.

Novel Formula Im1 compounds inhibit 11β-HSD1 enzyme activity to treat metabolic disorders.

An FCHo1 activity regulator targets the protein essential for midbody formation during cell division.

Monoacylglycerol lipase inhibitors reverse fibrotic scarring through matrix metalloproteinase activation, restoring organ architecture and function.

Reversible nitrogen oxides of nitroalkenes decompose to release nitric oxide, inducing vasodilation while minimizing gastrointestinal side effects.

Formula I' compounds bind allosteric sites to inhibit mutant EGFR, overcoming T790M and C797S resistance mutations.

Adjusting aqueous phase pH increases active ingredient ionization, resolving low drug loading efficiency in histone deacetylase inhibitor nanoparticles.

Aminoquinazolinyl compounds block prolyl hydroxylase activity, resolving the lack of potent modulators for anemia and wound healing.

A nitrogen-containing heterocyclic compound inhibits CXCL10 through specific quinoline core substitution.

Adjusting pimavanserin doses for cytochrome P450 inhibitor interactions prevents toxicity while maintaining therapeutic efficacy.

mRNA-encoded TALEN monomers dimerize to cleave HBV cccDNA, eliminating the persistent viral template that current treatments fail to remove.

Synthetic block polymers neutralize heparin through electrostatic interactions.

A resiliently deformable receptacle wall maintains contact with the treatment surface to spread liquid effectively.

Hydrophobic lactam prodrug moieties reduce polarity to form an insoluble depot, resolving irregular release patterns and unreliable rate control.

Annealing an antisense oligonucleotide with a lipid-conjugated complementary strand creates a complex that increases delivery efficiency to ischemic sites.

Optimizing daily flibanserin dosage resolves the contradiction between therapeutic effectiveness and sedative side effects.

Modified sanglifehrin analogues resist rapid metabolism to extend half-life and reduce side effects in HCV and HIV treatment.

Formula I compounds modulate the integrated stress response pathway through specific aromatic heterocyclyl derivatives.

Tethered inhibitors bind eHsp90 on activated T cells, resolving the trade-off between disease control and broad immunosuppression side effects.

Gastroresistant polymer coatings on lipoic acid pellets protect chemical integrity from gastric degradation while enabling sustained bioavailability.

Active agents enhance oligonucleotide intracellular delivery via clathrin-mediated endocytosis pathways.

A segmented production method for pyrazole-amide compounds uses palladium catalyzed coupling to achieve high yield synthesis.

Stapled peptides activate ALMS1-mediated glucose uptake in adipose tissue, resolving the trade-off between glycemic control and hypoglycemia risk.

Dihydroisoquinoline compounds inhibit Protein Arginine Methyltransferase 5 activity through specific molecular recognition features.

High-output vibrating mesh nebulizers deliver iloprost as an aerosol bolus, reducing treatment time to under two minutes while maintaining haemodynamic safety.

Novel fused heterocyclic compounds inhibit late sodium current to treat cardiovascular diseases and diabetes.

Single-step aqueous hydrogen peroxide oxidation eliminates toxic catalysts, achieving high purity 4-hydroxymethylbutenolide yields.

GalNAc-conjugated antisense oligonucleotides lower triglyceride and cholesterol concentrations by selectively inhibiting ANGPTL3 expression in hepatocytes.

Amino acid-linked furazanobenzimidazoles improve parenteral formulation by increasing water solubility while maintaining therapeutic efficacy.

Oral protocatechuic acid drives bone and cartilage regeneration via anabolic cytokines, replacing metal implants to eliminate infection risks.

An oligomerized polyphenol layer bonds to polymer top coats on medical devices to promote fibrinogen adsorption and blood clotting.